Pandemic Drugs at Pandemic Speed: Infrastructure for Accelerating COVID-19 Drug Discovery with Hybrid Machine Learning- and Physics-based Simulations on High Performance Computers
Authors:
Agastya P. Bhati,
Shunzhou Wan,
Dario Alfè,
Austin R. Clyde,
Mathis Bode,
Li Tan,
Mikhail Titov,
Andre Merzky,
Matteo Turilli,
Shantenu Jha,
Roger R. Highfield,
Walter Rocchia,
Nicola Scafuri,
Sauro Succi,
Dieter Kranzlmüller,
Gerald Mathias,
David Wifling,
Yann Donon,
Alberto Di Meglio,
Sofia Vallecorsa,
Heng Ma,
Anda Trifan,
Arvind Ramanathan,
Tom Brettin,
Alexander Partin
, et al. (4 additional authors not shown)
Abstract:
The race to meet the challenges of the global pandemic has served as a reminder that the existing drug discovery process is expensive, inefficient and slow. There is a major bottleneck screening the vast number of potential small molecules to shortlist lead compounds for antiviral drug development. New opportunities to accelerate drug discovery lie at the interface between machine learning methods…
▽ More
The race to meet the challenges of the global pandemic has served as a reminder that the existing drug discovery process is expensive, inefficient and slow. There is a major bottleneck screening the vast number of potential small molecules to shortlist lead compounds for antiviral drug development. New opportunities to accelerate drug discovery lie at the interface between machine learning methods, in this case developed for linear accelerators, and physics-based methods. The two in silico methods, each have their own advantages and limitations which, interestingly, complement each other. Here, we present an innovative infrastructural development that combines both approaches to accelerate drug discovery. The scale of the potential resulting workflow is such that it is dependent on supercomputing to achieve extremely high throughput. We have demonstrated the viability of this workflow for the study of inhibitors for four COVID-19 target proteins and our ability to perform the required large-scale calculations to identify lead antiviral compounds through repurposing on a variety of supercomputers.
△ Less
Submitted 4 September, 2021; v1 submitted 4 March, 2021;
originally announced March 2021.
When we can trust computers (and when we can't)
Authors:
Peter V. Coveney,
Roger R. Highfield
Abstract:
With the relentless rise of computer power, there is a widespread expectation that computers can solve the most pressing problems of science, and even more besides. We explore the limits of computational modelling and conclude that, in the domains of science and engineering that are relatively simple and firmly grounded in theory, these methods are indeed powerful. Even so, the availability of cod…
▽ More
With the relentless rise of computer power, there is a widespread expectation that computers can solve the most pressing problems of science, and even more besides. We explore the limits of computational modelling and conclude that, in the domains of science and engineering that are relatively simple and firmly grounded in theory, these methods are indeed powerful. Even so, the availability of code, data and documentation, along with a range of techniques for validation, verification and uncertainty quantification, are essential for building trust in computer generated findings. When it comes to complex systems in domains of science that are less firmly grounded in theory, notably biology and medicine, to say nothing of the social sciences and humanities, computers can create the illusion of objectivity, not least because the rise of big data and machine learning pose new challenges to reproducibility, while lacking true explanatory power. We also discuss important aspects of the natural world which cannot be solved by digital means. In the long-term, renewed emphasis on analogue methods will be necessary to temper the excessive faith currently placed in digital computation.
△ Less
Submitted 8 July, 2020;
originally announced July 2020.